Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Change in Interest Receivables (2020 - 2021)

BioAtla's Change in Interest Receivables history spans 2 years, with the latest figure at -$2000.0 for Q2 2021.

  • For Q2 2021, Change in Interest Receivables rose 99.83% year-over-year to -$2000.0; the TTM value through Mar 2022 reached -$2000.0, up 99.84%, while the annual FY2021 figure was -$3000.0, 99.65% up from the prior year.
  • Change in Interest Receivables reached -$2000.0 in Q2 2021 per BCAB's latest filing, down from -$1000.0 in the prior quarter.
  • In the past five years, Change in Interest Receivables ranged from a high of $379000.0 in Q1 2020 to a low of -$1.2 million in Q2 2020.